An immunoprophylactic evaluation of Ld-ODC derived HLA-A0201 restricted peptides against visceral leishmaniasis

References

• Abele, R., & Tampé, R. (2004). The ABCs of immunology: Structure and function of TAP, the transporter associated with antigen processing. Physiology, 19(4), 216–224. https://doi.org/https://doi.org/10.1152/physiol.00002.2004
   PubMedGoogle Scholar
• Afrin, F., Rajesh, R., Anam, K., Gopinath, M., Pal, S., & Ali, N. (2002). Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice. Infection and Immunity, 70(12), 6697–6706. https://doi.org/https://doi.org/10.1128/iai.70.12.6697-6706.2002
   PubMed Web of Science ®Google Scholar
• Agrawal, S., Rai, M., & Sundar, S. (2005). Management of visceral leishmaniasis: Indian perspective. Journal of Postgraduate Medicine, 51(5), 53–57. https://www.jpgmonline.com/article.asp?issn=0022-3859;year=2005;volume=51;issue=5;spage=53;epage=57;aulast=
   Google Scholar
• Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M.; WHO Leishmaniasis Control Team (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS One, 7(5), e35671. https://doi.org/https://doi.org/10.1371/journal.pone.0035671
   Google Scholar
• Amit, A., Dikhit, M. R., Singh, A. K., Kumar, V., Suman, S. S., Singh, A., Kumar, A., Thakur, A. K., Das, V. R., Das, P., & Bimal, S. (2017). Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice. Molecular Immunology, 82, 104–113. https://doi.org/https://doi.org/10.1016/j.molimm.2016.12.022
   PubMed Web of Science ®Google Scholar
• Andrusier, N., Nussinov, R., & Wolfson, H. J. (2007). FireDock: Fast interaction refinement in molecular docking. Proteins, 69(1), 139–159. https://doi.org/https://doi.org/10.1002/prot.21495
   PubMed Web of Science ®Google Scholar
• Bacik, I., Cox, J. H., Anderson, R., Yewdell, J. W., & Bennink, J. R. (1994). TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. The Journal of Immunology, 152(2), 381–387. https://www.jimmunol.org/content/152/2/381.long
   PubMed Web of Science ®Google Scholar
• Basu, R., Bhaumik, S., Basu, J. M., Naskar, K., De, T., & Roy, S. (2005). Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: Evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. Journal of Immunology, 174(11), 7160–7171. https://doi.org/https://doi.org/10.4049/jimmunol.174.11.7160
   PubMed Web of Science ®Google Scholar
• Bhasin, M., & Raghava, G. P. S. (2004). Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Science : A Publication of the Protein Society, 13(3), 596–607. https://doi.org/https://doi.org/10.1110/ps.03373104
   PubMed Web of Science ®Google Scholar
• Bimal, S., Singh, S. K., Sinha, S., Pandey, K., Sinha, P. K., Ranjan, A., Bhattacharya, S. K., & Das, P. (2008). Leishmania donovani: Role of CD2 on CD4+ T-cell function in Visceral leishmaniasis. Experimental Parasitology, 118(2), 238–246. https://doi.org/https://doi.org/10.1016/j.exppara.2007.08.009
   PubMed Web of Science ®Google Scholar
• Bui, H. H., Sidney, J., Dinh, K., Southwood, S., Newman, M. J., & Sette, A. (2006). Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics, 7(1), 153. https://doi.org/https://doi.org/10.1186/1471-2105-7-153
   PubMed Web of Science ®Google Scholar
• Bui, H. H., Sidney, J., Li, W., Fusseder, N., & Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics, 8(1), 361. https://doi.org/https://doi.org/10.1186/1471-2105-8-361
   PubMed Web of Science ®Google Scholar
• Calis, J. J., Maybeno, M., Greenbaum, J. A., Weiskopf, D., De Silva, A. D., Sette, A., Keşmir, C., & Peters, B. (2013). Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Computational Biology, 9(10), e1003266. https://doi.org/https://doi.org/10.1371/journal.pcbi.1003266
   PubMed Web of Science ®Google Scholar
• Cardoso, T. M., Machado, Á., Costa, D. L., Carvalho, L. P., Queiroz, A., Machado, P., Scott, P., Carvalho, E. M., Bacellar, O. (2015). Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection. Infection and Immunity, 83(3), 898-906. https://doi.org/https://doi.org/10.1128/IAI.02404-14
   Google Scholar
• Coler, R. N., Goto, Y., Bogatzki, L., Raman, V., & Reed, S. G. (2007). Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells. Infection and Immunity, 75(9), 4648–4654. https://doi.org/https://doi.org/10.1128/IAI.00394-07
   PubMed Web of Science ®Google Scholar
• Colotti, G., Ilari, A. (2011). Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids, 40(2), 269–285. https://doi.org/https://doi.org/10.1007/s00726-010-0630-3
   Google Scholar
• Dikhit, M. R., Das, S., Mahantesh, V., Kumar, A., Singh, A. K., Dehury, B., Rout, A. K., Ali, V., Sahoo, G. C., Topno, R. K., Pandey, K. (2018). The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response. Scientific Reports, 8(1), 1–13. https://doi.org/https://doi.org/10.1038/s41598-018-32040-x
   PubMedGoogle Scholar
• Dikhit, M. R., Kumar, S., Sahoo, B. R., Mansuri, R., Amit, A., Ansari, M. Y., Sahoo, G. C., Bimal, S., & Das, P. (2015). Computational elucidation of potential antigenic CTL epitopes in Ebola virus. Infection, Genetics and Evolution, 36, 369–375. https://doi.org/https://doi.org/10.1016/j.meegid.2015.10.012
   PubMed Web of Science ®Google Scholar
• Ganguly, S., Das, N. K., Barbhuiya, J. N., & Chatterjee, M. (2010). Post-kala-azar dermal leishmaniasis – An overview. International Journal of Dermatology, 49(8), 921–931. https://doi.org/https://doi.org/10.1111/j.1365-4632.2010.04558.x
   PubMed Web of Science ®Google Scholar
• Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., & Raghava, G. P. (2013). In silico approach for predicting toxicity of peptides and proteins. PloS One, 8(9), e73957. https://doi.org/https://doi.org/10.1371/journal.pone.0073957
   PubMed Web of Science ®Google Scholar
• Jain, K., & Jain, N. K. (2015). Vaccines for visceral leishmaniasis: A review. Journal of Immunological Methods, 422, 1–12. https://doi.org/https://doi.org/10.1016/j.jim.2015.03.017
   PubMed Web of Science ®Google Scholar
• Joshi, S., Rawat, K., Yadav, N. K., Kumar, V., Siddiqi, M. I., & Dube, A. (2014). Visceral leishmaniasis: Advancements in vaccine development via classical and molecular approaches. Frontiers in Immunology, 5, 380. https://doi.org/https://doi.org/10.3389/fimmu.2014.00380
   PubMed Web of Science ®Google Scholar
• Kaushal, H., Bras-Gonçalves, R., Negi, N. S., Lemesre, J. L., Papierok, G., & Salotra, P. (2014). Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral leishmaniasis individuals. BMC Infectious Diseases, 14(1), 653. https://doi.org/https://doi.org/10.1186/s12879-014-0653-6
   PubMedGoogle Scholar
• Kelly, B. L., Stetson, D. B., & Locksley, R. M. (2003). Leishmania major LACK antigen is required for efficient vertebrate parasitization. The Journal of Experimental Medicine, 198(11), 1689–1698. https://doi.org/https://doi.org/10.1084/jem.20031162
   PubMed Web of Science ®Google Scholar
• Kemp, K., Kemp, M., Kharazmi, A., Ismail, A., Kurtzhals, J. A. L., Hviid, L., & Theander, T. G. (1999). Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clinical and Experimental Immunology, 116 (3), 500–504. https://doi.org/https://doi.org/10.1046/j.1365-2249.1999.00918.x
   PubMed Web of Science ®Google Scholar
• Killeen, N., Stuart, S. G., & Littman, D. R. (1992). Development and function of T cells in mice with a disrupted CD2 gene. The EMBO Journal, 11(12), 4329–4336. https://doi.org/https://doi.org/10.1002/j.1460-2075.1992.tb05532.x
   PubMed Web of Science ®Google Scholar
• Kima, P. E., & Soong, L. (2013). Interferon gamma in leishmaniasis. Frontiers in Immunology, 4, 156. https://doi.org/https://doi.org/10.3389/fimmu.2013.00156
   PubMed Web of Science ®Google Scholar
• Kolaskar, A. S., & Tongaonkar, P. C. (1990). A semi‐empirical method for prediction of antigenic determinants on protein antigens. FEBS Letters, 276(1–2), 172–174. https://doi.org/https://doi.org/10.1016/0014-5793(90)80535-Q
   PubMed Web of Science ®Google Scholar
• Kumar, A., Dikhit, M. R., Amit, A., Zaidi, A., Pandey, R. K., Singh, A. K., Suman, S. S., Ali, V., Das, V. N. R., Pandey, K., Kumar, V., Singh, S. K., Narayan, S., Chourasia, H. K., Das, P., & Bimal, S. (2018). Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb/c mice infected with Leishmania donovani. Molecular Immunology, 97, 33–44. https://doi.org/https://doi.org/10.1016/j.molimm.2018.03.004
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit, B., & Tampé, R. (1999). The transporter associated with antigen processing TAP: Structure and function. FEBS Letters, 464(3), 108–112. https://doi.org/https://doi.org/10.1016/S0014-5793(99)01676-2
   PubMed Web of Science ®Google Scholar
• Liu, D., & Uzonna, J. E. (2012). The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Frontiers in Cellular and Infection Microbiology, 2, 83. https://doi.org/https://doi.org/10.3389/fcimb.2012.00083
   PubMed Web of Science ®Google Scholar
• Lokhande, K. B., Nagar, S., & Swamy, K. V. (2019). Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach. Scientific Reports, 9(1), 1–13. https://doi.org/https://doi.org/10.1038/s41598-018-38332-6
   PubMedGoogle Scholar
• Maupetit, J., Derreumaux, P., & Tuffery, P. (2009). PEP-FOLD: An online resource for de novo peptide structure prediction. Nucleic Acids Research, 37(Web Server issue), W498–W503. https://doi.org/https://doi.org/10.1093/nar/gkp323
   PubMedGoogle Scholar
• Nielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Røder, G., Peters, B., Sette, A., Lund, O., & Buus, S. (2007). NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and-B locus protein of known sequence. PloS One, 2(8), e796. https://doi.org/https://doi.org/10.1371/journal.pone.0000796
   PubMed Web of Science ®Google Scholar
• Okwor, I., Uzonna, J. (2016). Social and economic burden of human leishmaniasis. American Journal of Tropical Medicine and Hygiene, 94(3), 489–493. https://doi.org/https://doi.org/10.4269/ajtmh.15-0408
   Google Scholar
• Osman, M., Mistry, A., Keding, A., Gabe, R., Cook, E., Forrester, S., Wiggins, R., Di Marco, S., Colloca, S., Siani, L., Cortese, R., Smith, D. F., Aebischer, T., Kaye, P. M., & Lacey, C. J. (2017). A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Neglected Tropical Diseases, 11(5), e0005527. https://doi.org/https://doi.org/10.1371/journal.pntd.0005527
   PubMed Web of Science ®Google Scholar
• Pandey, R., Ranjan Dikhit, M., Kumar, A., Dehury, B., Pandey, K., Topno, R. K., Das, P., & Bimal, S. (2020). Evaluating the immunomodulatory responses of LdODC derived MHC Class‐II restricted peptides against VL. Parasite Immunology, 42(4), e12699. https://doi.org/https://doi.org/10.1111/pim.12699
   PubMed Web of Science ®Google Scholar
• Peters, B., Bulik, S., Tampe, R., Van Endert, P. M., & Holzhütter, H. G. (2003). Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. The Journal of Immunology, 171(4), 1741–1749. https://doi.org/https://doi.org/10.4049/jimmunol.171.4.1741
   PubMed Web of Science ®Google Scholar
• Raman, V. S., Reed, S. G., Duthie, M. S., Fox, C. B., & Matlashewski, G. (2012). Adjuvants for Leishmania vaccines: From models to clinical application. Frontiers in Immunology, 3, 144. https://doi.org/https://doi.org/10.3389/fimmu.2012.00144
   PubMed Web of Science ®Google Scholar
• Ready, P. D. (2014). Epidemiology of visceral leishmaniasis. Clinical Epidemiology, 6, 147-154. https://doi.org/https://doi.org/10.2147/CLEP.S44267
   Google Scholar
• Ribeiro-Gomes, F. L., & Sacks, D. (2012). The influence of early neutrophil-Leishmania interactions on the host immune response to infection. Frontiers in Cellular and Infection Microbiology, 2, 59. https://doi.org/https://doi.org/10.3389/fcimb.2012.00059
   Google Scholar
• Sachdeva, R., Banerjea, A. C., Malla, N., & Dubey, M. L. (2009). Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model. PLoS One, 4(12), e7880. https://doi.org/https://doi.org/10.1371/journal.pone.0007880
   PubMed Web of Science ®Google Scholar
• Shey, R. A., Ghogomu, S. M., Esoh, K. K., Nebangwa, N. D., Shintouo, C. M., Nongley, N. F., Asa, B. F., Ngale, F. N., Vanhamme, L., & Souopgui, J. (2019). In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Scientific Reports, 9(1), 1–18. https://doi.org/https://doi.org/10.1038/s41598-019-40833-x
   PubMed Web of Science ®Google Scholar
• Sinha, S., Kumar, A., & Sundaram, S. (2013). A comprehensive analysis of LACK (Leishmania homologue of receptors for activated C kinase) in the context of Visceral leishmaniasis. Bioinformation, 9(16), 832–837. https://doi.org/https://doi.org/10.6026/97320630009832
   PubMedGoogle Scholar
• Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015). An overview of bioinformatics tools for epitope prediction: Implications on vaccine development. Journal of Biomedical Informatics, 53, 405–414. https://doi.org/https://doi.org/10.1016/j.jbi.2014.11.003
   PubMed Web of Science ®Google Scholar
• Srivastava, P., Prajapati, V. K., Rai, M., & Sundar, S. (2011). Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic. Journal of Clinical Microbiology, 49(8), 3088–3091. https://doi.org/https://doi.org/10.1128/JCM.00173-11
   PubMed Web of Science ®Google Scholar
• Stäger, S., Smith, D. F., & Kaye, P. M. (2000). Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. Journal of Immunology, 165(12), 7064–7071. https://doi.org/https://doi.org/10.4049/jimmunol.165.12.7064
   PubMed Web of Science ®Google Scholar
• Sundar, S., & Singh, A. (2016). Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic Advances in Infectious Disease, 3(3–4), 98–109. https://doi.org/https://doi.org/10.1177/2049936116646063
   PubMed Web of Science ®Google Scholar
• Tomiotto-Pellissier, F., Bortoleti, B. T. D. S., Assolini, J. P., Gonçalves, M. D., Carloto, A. C. M., Miranda-Sapla, M. M., Conchon-Costa, I., Bordignon, J., & Pavanelli, W. R. (2018). Macrophage polarization in leishmaniasis: Broadening horizons. Frontiers in Immunology, 9, 2529. https://doi.org/https://doi.org/10.3389/fimmu.2018.02529
   PubMed Web of Science ®Google Scholar
• Trost, B., Bickis, M., Kusalik, A. (2007). Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools. Immunome Research, 3, 5–15.
   Google Scholar
• Uzonna, J. E., Joyce, K. L., & Scott, P. (2004). Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. The Journal of Experimental Medicine, 199(11), 1559–1566. https://doi.org/https://doi.org/10.1084/jem.20040172
   PubMed Web of Science ®Google Scholar
• Wieczorek, M., Abualrous, E. T., Sticht, J., Álvaro-Benito, M., Stolzenberg, S., Noé, F., & Freund, C. (2017). Major histocompatibility complex (MHC) class I and MHC class II proteins: Conformational plasticity in antigen presentation. Frontiers in Immunology, 8, 292. https://doi.org/https://doi.org/10.3389/fimmu.2017.00292
   PubMed Web of Science ®Google Scholar
• Yadav, A., Amit, A., Chaudhary, R., Chandel, A. S., Mahantesh, V., Suman, S. S., Singh, S. K., Dikhit, M. R., Ali, V., Rabidas, V., Pandey, K., Kumar, A., Das, P., & Bimal, S. (2015). Leishmania donovani: Impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. International Journal for Parasitology, 45(1), 33–42. https://doi.org/https://doi.org/10.1016/j.ijpara.2014.08.013
   PubMed Web of Science ®Google Scholar